FindMyRecallSubscribe
Class I: serious health riskOngoing

American Regent Epinephrine Injection Recall

Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, Fo…

American Regent, Inc. · Shirley, NY

Risk level
Class I
Reported by FDA
Sep 16, 2026
Recall ID
D-0865-2026
Check your lot numberHow we source this data

Summary

American Regent recalled Epinephrine Injection starting Aug 11, 2026. The FDA classified it as Class I (serious health risk) and published enforcement report D-0865-2026 on Sep 16, 2026. Reason: Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

Product description

Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN REGENT INC., SHIRLEY, NY 11967. NDC 0517-3030-01

Lot numbers, UPCs & expiration codes

Lots: 25128L1C0, Exp. August 31, 2026; 25280L1C0, Exp. October 31, 2026; 26108L1C0, Exp. July 31, 2027

Where it was sold

Nationwide within the U.S.A

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0865-2026
Classification
Class I
Status
Ongoing
Recall initiated
Aug 11, 2026
FDA report date
Sep 16, 2026
Quantity
31,935 30mL-vials
Recall type
Voluntary: Firm initiated
Recalling firm
American Regent, Inc.

Original FDA data

Every field from FDA enforcement report D-0865-2026, exactly as published.

Show all FDA fields
City
Shirley
State
NY
Status
Ongoing
Country
United States
Event ID
99670
Address
5 Ramsay Rd
Code information
Lots: 25128L1C0, Exp. August 31, 2026; 25280L1C0, Exp. October 31, 2026; 26108L1C0, Exp. July 31, 2027
Postal code
11967-4701
Report date
Sep 16, 2026
Product type
Drugs
Recall number
D-0865-2026
Classification
Class I
Recalling firm
American Regent, Inc.
Product quantity
31,935 30mL-vials
Reason for recall
Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN REGENT INC., SHIRLEY, NY 11967. NDC 0517-3030-01
Distribution pattern
Nationwide within the U.S.A
Recall initiation date
Aug 11, 2026
Initial firm notification
Letter
Center classification date
Sep 22, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0865-2026, published Sep 16, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls